Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy
- PMID: 30635237
- DOI: 10.1016/j.immuni.2018.12.021
Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy
Abstract
Checkpoint blockade mediates a proliferative response of tumor-infiltrating CD8+ T lymphocytes (TILs). The origin of this response has remained elusive because chronic activation promotes terminal differentiation or exhaustion of tumor-specific T cells. Here we identified a subset of tumor-reactive TILs bearing hallmarks of exhausted cells and central memory cells, including expression of the checkpoint protein PD-1 and the transcription factor Tcf1. Tcf1+PD-1+ TILs mediated the proliferative response to immunotherapy, generating both Tcf1+PD-1+ and differentiated Tcf1-PD-1+ cells. Ablation of Tcf1+PD-1+ TILs restricted responses to immunotherapy. Tcf1 was not required for the generation of Tcf1+PD-1+ TILs but was essential for the stem-like functions of these cells. Human TCF1+PD-1+ cells were detected among tumor-reactive CD8+ T cells in the blood of melanoma patients and among TILs of primary melanomas. Thus, immune checkpoint blockade relies not on reversal of T cell exhaustion programs, but on the proliferation of a stem-like TIL subset.
Keywords: T cell exhaustion; T cell factor 1; T cell reinvigoration; cancer immunotherapy; checkpoint blockade; memory-like T cells; stem-like T cells; therapeutic vaccination.
Copyright © 2018 Elsevier Inc. All rights reserved.
Comment in
-
The First Shall (Be) Last: Understanding Durable T Cell Responses in Immunotherapy.Immunity. 2019 Jan 15;50(1):6-8. doi: 10.1016/j.immuni.2018.12.029. Immunity. 2019. PMID: 30650381
Similar articles
-
Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1-CD8+ Tumor-Infiltrating T Cells.Immunity. 2019 Jan 15;50(1):181-194.e6. doi: 10.1016/j.immuni.2018.11.014. Epub 2019 Jan 8. Immunity. 2019. PMID: 30635236 Free PMC article.
-
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.Nat Immunol. 2019 Mar;20(3):326-336. doi: 10.1038/s41590-019-0312-6. Epub 2019 Feb 18. Nat Immunol. 2019. PMID: 30778252 Free PMC article.
-
PD-1 blockade-unresponsive human tumor-infiltrating CD8+ T cells are marked by loss of CD28 expression and rescued by IL-15.Cell Mol Immunol. 2021 Feb;18(2):385-397. doi: 10.1038/s41423-020-0427-6. Epub 2020 Apr 24. Cell Mol Immunol. 2021. PMID: 32332901 Free PMC article.
-
Intratumoral CD8+ T cells with stem cell-like properties: Implications for cancer immunotherapy.Sci Transl Med. 2019 Oct 23;11(515):eaay6863. doi: 10.1126/scitranslmed.aay6863. Sci Transl Med. 2019. PMID: 31645454 Review.
-
CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions.Annu Rev Med. 2018 Jan 29;69:301-318. doi: 10.1146/annurev-med-012017-043208. Annu Rev Med. 2018. PMID: 29414259 Review.
Cited by
-
Chemokines and the immune response to cancer.Immunity. 2021 May 11;54(5):859-874. doi: 10.1016/j.immuni.2021.01.012. Epub 2021 Apr 10. Immunity. 2021. PMID: 33838745 Free PMC article. Review.
-
Cancer Cell Small Molecule Secretome Induces the Immune Checkpoint NKG2A and Dysfunction of Human CD8+ T Cells.Immunohorizons. 2024 Jun 1;8(6):464-477. doi: 10.4049/immunohorizons.2400046. Immunohorizons. 2024. PMID: 38922288 Free PMC article.
-
Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8+ T cell exhaustion and anti-PD-1 resistance.Cell Rep Med. 2024 Aug 20;5(8):101686. doi: 10.1016/j.xcrm.2024.101686. Cell Rep Med. 2024. PMID: 39168104 Free PMC article.
-
Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity.Nat Commun. 2024 Jan 24;15(1):683. doi: 10.1038/s41467-024-44789-z. Nat Commun. 2024. PMID: 38267402 Free PMC article.
-
Nanoparticle-Based Immunotherapy for Reversing T-Cell Exhaustion.Int J Mol Sci. 2024 Jan 23;25(3):1396. doi: 10.3390/ijms25031396. Int J Mol Sci. 2024. PMID: 38338674 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous